LOINC Code 104127-6: Cytokeratin 19 mRNA for cancer metastasis NAA+non-probe Ql (Lymph node)

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Cytokeratin 19 mRNA for cancer metastasis. It is commonly used with the system or sample type Lymph node.

When is it used?

• Used in lab systems, EHRs, and clinical data exchange.
• May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
• Status: ACTIVE
• Order vs observation: Both
• Method: Non-probe.amp.tar

What it does not mean

• The code identifies the observation or test, not the actual result.

Key facts

• Cytokeratin 19 mRNA for cancer metastasis [Presence] in Lymph node by NAA with non-probe detection
• Cytokeratin 19 mRNA for cancer metastasis
• 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Autoimmune hepatitis; CK; CK 19; CK19; CK-19; CK19 mRNA metastasis; Cyfra 21-1; DNA NUCLEIC ACID PROBE; DNA probe; Keratin 19; Keratin, type I cytoskeletal 19; keratin-19 (K19); LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Ln; Metastases; Mets; NAA+n-prb; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PATHOLOGY; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Frequently asked questions